Skip to content
Open access

Serum per- and polyfluoroalkyl substances and prevalent heart disease: cross-sectional analysis of the multi-site study.

Sep 2026 · Environment International · Vol 216, pp. 110522 · 0 citations · 44 references
Medicine

TL;DR

A large, cross-sectional, multi-site study of adults residing in communities in the United States with historic PFAS drinking water contamination suggests largely null associations between serum PFAS and self-reported heart disease.

Abstract

Previous research investigating exposure to per- and polyfluoroalkyl substances (PFAS) and their association with heart disease has found conflicting results, with recent studies reporting null or inverse associations. We estimated associations between serum PFAS and prevalent heart disease in a large, cross-sectional, multi-site study of adults residing in communities in the United States with historic PFAS drinking water contamination. Participants were recruited from communities in eight states (2019-2023), where they completed questionnaires and provided blood samples. PFAS concentrations were measured in serum. Four PFAS detected in > 70% of participants were modeled as continuous variables, and three less-frequently detected PFAS were modeled as binary variables (above/below the limit of detection). Logistic regression models estimated associations between each PFAS and prevalent heart disease based on self-report, adjusting for demographics, smoking and alcohol consumption, waist-to-hip ratio, estimated glomerular filtration rate (eGFR), and study site. Quantile g-computation models were used to estimate the joint effects of PFAS as a mixture. A total of 5,761 adult participants were included in the analysis, with a mean age of 56 years and 60.2% female. The prevalence of self-reported heart disease was 9.2%. Adjusted analyses showed no statistically significant associations between all PFAS and self-reported heart disease. Our mixture analysis revealed no association between PFAS as a mixture and prevalent self-reported heart disease (OR: 0.99, 95% CI: 0.95-1.03). Our findings suggest largely null associations between serum PFAS and self-reported heart disease.

Read PDF

Similar papers

Review Oct 2026

B-382 Associations of Serum Per- and Polyfluoroalkyl Substances (PFAS) Levels with Clinical Indicators in a Clinical Patient Cohort

Per- and polyfluoroalkyl substances (PFAS) are ubiquitous and persistent environmental contaminants. Extensive population-based biomonitoring has confirmed the widespread of PFAS in the general population. In 2022, National Academies of Sciences, Engineering, and Medicine (NASEM) issued clinical guidance recommen...

Dui Wen · 0 citations
Open access Sep 2026

Association between plasma levels of per- and polyfluoroalkyl substances and schizophrenia: A case-control study.

In the assessment of mixture exposure effects, the BKMR model indicated an overall negative association between PFAS mixtures and schizophrenia risk, and gWQS analysis further identified PFHxS as the component with the highest weight contribution.

Xu-Lu Gao, Tian-Xian Wang, Yu-Yu He et al. · 0 citations
Open access Sep 2026

Age-specific associations between childhood per- and polyfluoroalkyl substances exposure and blood lipid profiles: a prospective birth cohort study

Per- and polyfluoroalkyl substances (PFAS) are persistent synthetic chemicals detected in populations, including children, through exposure from food, drinking water, and consumer products. Although growing evidence links PFAS exposure to altered pediatric lipid profiles, few longitudinal studies have determined...

Ji-Eun Lee, Dong-Wook Lee, Youn-Hee Lim et al. · 0 citations
Open access Sep 2026

Maternal per- and polyfluoroalkyl substances exposure and the co-occurrence of gestational diabetes mellitus and preeclampsia/eclampsia: a nested case–control study

Objective Few studies have investigated the relationship between maternal exposure to per- and polyfluoroalkyl substances (PFAS) and the co-occurrence of gestational diabetes mellitus (GDM) and hypertensive disorders of pregnancy, particularly preeclampsia/eclampsia (PE/E). The present study aimed to explore whether PF...

Na-Na Li, Lu Li, Ying Deng et al. · 0 citations
Open access Aug 2026

Serum concentrations of legacy, alternative, and precursor per- and polyfluoroalkyl substances: a descriptive analysis of premenopausal participants in the Canadian CARTaGENE cohort

The findings suggest that exposure to low levels of some alternative and precursor PFAS may be widespread in Canada and reinforce the role of pregnancy and breastfeeding as excretion pathways for legacy PFAS and support previous investigations demonstrating that exposure to some PFAS may be lower amongst financially di...

M. Borghese, Rebecca Lelievre, Sara Packull-McCormick et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.